Ozempic and other glucagon-like peptide-1 (GLP-1) agonists are a transformative new class of medicines for the treatment of diabetes and obesity, while also delivering other health benefits, such as ...

The remarkable efficacy of new diabetes and weight loss medicines like Ozempic and Mounjaro have been one of the biggest health stories of recent years. Despite rising rates of diabetes and obesity, ...

The GLP-1 receptor agonist exenatide failed to meet its primary outcome in a phase III trial of Parkinson's disease patients.

Set of 9 Micro-pens: This set contains 9 Black Multiliner pens with 8 different size head and 1 soft head,No Matter how you want to Draw，we have the right tip. Water-resistant :The fine-point ...

Ozempic has been approved to reduce the risk of worsening kidney disease and cardiovascular death in adults with Type 2 ...

Weight loss from GLP-1 meds can cause faces to sag, spurring a big uptick in plastic surgeries to correct so-called 'Ozempic face' Nose jobs, facelifts and eye lifts still top the list of most ...

Patients testing a new weight-loss drug developed by the creators of Ozempic have revealed the ... in the 24 hours after her weekly CagriSema injection are so bad that she sometimes can't leave ...

which already chips in on the development and commercial manufacturing of delivery devices like on-body pumps, inhalers, auto-injectors and injection pens.